Skip to main content

Drépanocytose et complications aiguës

  • Chapter
Maladies rares en médecine d’urgence

Part of the book series: Références en médecine d’urgence. Collection de la SFMU ((REFERMED))

  • 1185 Accesses

Résumé

La drépanocytose est la plus fréquente des hémoglobinopathies. D’origine génétique, elle est due à une mutation sur le chromosome 11 du gène de la β-globine. Cette variation autosomique récessive est à l’origine de la synthèse d’une hémoglobine anormale, l’hémoglobine S (HbS). Cette dernière présente des caractéristiques rhéologiques particulières aboutissant, dans certaines conditions, à la falciformation (déformation en faucille des hématies) et à la vaso-occlusion in situ, responsable de complications à court, moyen et long termes. L’hémoglobine C résulte de la mutation du gène β-globine (remplacement de l’acide aminé n∘ 6 glutamique par la lysine, en même position que la mutation drépanocytaire). Les formes génétiques principales sont les suivantes: sujets homozygote S/S, hétérozygote S/C, hétérozygote composite S/β ° ou S/β + thalassémies (β° pour un déficit total de synthèse des chaînes de β-globine et β+ pour un déficit partiel). Les patients hétérozygotes de type AS sont des porteurs sains, ne présentant pas de fait de manifestation pathologique liée à ce trait.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Suzan F, Paty AC (2012) Études descriptives de la mortalité et des hospitalisations liées à la drépanocytose en France. Bull Epidémiol Hebd 27–8

    Google Scholar 

  2. Gillis VL, Senthinathan A, Dzingina M et al. (2012) Management of an acute painful sickle cell episode in hospital: summary of NICE guidance. BMJ 344: e4063

    Article  PubMed  CAS  Google Scholar 

  3. Serjeant GR, Ceulaer CD, Lethbridge R et al. (1994) The painful crisis of homozygous sickle cell disease: clinical features. Br J Haematol 87: 586–591

    Article  PubMed  CAS  Google Scholar 

  4. Lionnet F, Hammoudi N, Stojanovic KS et al. (2012) Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 97: 1136–41

    Article  PubMed  Google Scholar 

  5. Ballas SK, Lusardi M (2005) Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol 79: 17–25

    Article  PubMed  Google Scholar 

  6. Tanabe P, Myers R, Zosel A et al. (2007) Emergency department management of acute pain episodes in sickle cell disease. Acad Emerg Med 14: 419–25

    PubMed  Google Scholar 

  7. Habibi A, Bachir D, Godeau B (2004) Les complications aiguës de la drépanocytose. Rev Prat 54: 1548–56

    PubMed  Google Scholar 

  8. Platt OS (2000) The acute chest syndrome of sickle cell disease. N Engl J Med 342: 1904–7

    Article  PubMed  CAS  Google Scholar 

  9. Maitre B, Habibi A, Roudot-Thoraval F et al. (2000) Acute chest syndrome in adults with sickle cell disease. Chest 117: 1386–92

    Article  PubMed  CAS  Google Scholar 

  10. Vichinsky EP, Styles LA, Colangelo LH et al. (1997) Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 89: 1787–92

    PubMed  CAS  Google Scholar 

  11. Powars D, Weidman JA, Odom-Maryon T et al. (1988) Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 67: 66–76

    CAS  Google Scholar 

  12. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH (2006) Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med 173: 1264–9

    Article  PubMed  Google Scholar 

  13. Castro O, Brambilla DJ, Thorington B et al. (1994) The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 84: 643–9

    PubMed  CAS  Google Scholar 

  14. Vichinsky EP, Neumayr LD, Earles AN et al. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 342: 1855–65

    Article  PubMed  CAS  Google Scholar 

  15. Quinn CT, Buchanan GR (1999) The acute chest syndrome of sickle cell disease. J Pediatr 135: 416–22

    Article  PubMed  CAS  Google Scholar 

  16. McMahon L, Mark E (1997) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34-1997. A 22-year-old man with a sickle cell crisis and sudden death. N Engl J Med 337: 1293–301

    Article  Google Scholar 

  17. Gladwin MT, Rodgers GP (2000) Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia. Lancet 355: 1476–8

    Article  PubMed  CAS  Google Scholar 

  18. Gladwin MT, Kato GJ, Weiner D et al. (2011) Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial. JAMA 305: 893–902

    Article  PubMed  CAS  Google Scholar 

  19. Gladwin MT, Vichinsky E (2008) Pulmonary complications of sickle cell disease. N Engl J Med 359: 2254–65

    Article  PubMed  CAS  Google Scholar 

  20. Mantadakis E, Cavender JD, Rogers ZR et al. (1999) Prevalence of priapism in children and adolescents with sickle cell anemia. J Pediatr Hematol Oncol 21: 518–22

    Article  PubMed  CAS  Google Scholar 

  21. Ramos CE, Park JS, Ritchey ML, Benson GS (1995) High flow priapism associated with sickle cell disease. J Urol 153: 1619–21

    Article  PubMed  CAS  Google Scholar 

  22. Lionnet F, Arlet JB, Bartolucci P et al. (2009) Recommandations pratiques de prise en charge de la drépanocytose de l’adulte. Rev Med Interne 30(Suppl 3): S162–223

    Article  PubMed  Google Scholar 

  23. Micel L, Nuss R, Fenton L et al. (2011) Non-palpable splenic enlargement as the etiology of abdominal pain in an adolescent with hemoglobin SC disease. Pediatr Blood Cancer 57: 352–53

    Article  PubMed  Google Scholar 

  24. Koduri PR, Kovarik P (2006) Acute splenic sequestration crisis in an adult with sickle beta-thalassemia. Ann Hematol 85: 633–635

    Article  PubMed  Google Scholar 

  25. Brousse V, Elie C, Benkerrou M et al. (2012) Acute splenic sequestration crisis in sickle cell disease: cohort study of 190 paediatric patients. Br J Haematol 156: 643–648

    Article  PubMed  Google Scholar 

  26. Koduri PR, Kovarik P (2006) Acute splenic sequestration crisis in an adult with sickle beta-thalassemia. Ann Hematol 85: 633–635

    Article  PubMed  Google Scholar 

  27. Githens JH, Gross GP, Eife RF, Wallner SF (1977) Splenic sequestration syndrome at mountain altitudes in sickle/hemoglobin C disease. J Pediatr 90: 203–6

    Article  PubMed  CAS  Google Scholar 

  28. Mallouh AA, Qudah A (1993) Acute splenic sequestration together with aplastic crisis caused by human parvovirus B19 in patients with sickle cell disease. J Pediatr 122: 593–5

    Article  PubMed  CAS  Google Scholar 

  29. Bond LR, Hatty SR, Horn ME et al. (1987) Gall stones in sickle cell disease in the United Kingdom. Br Med J (Clin Res Ed) 295: 234–6

    Article  CAS  Google Scholar 

  30. Green TW, Conley CL, Berthrong M (1953) [The liver in sickle cell anemia]. Bull Johns Hopkins Hosp 92: 99–127

    PubMed  CAS  Google Scholar 

  31. Song YS (1957) Hepatic lesions in sickle cell anemia. Am J Pathol 33: 331–51

    PubMed  CAS  Google Scholar 

  32. Banerjee S, Owen C, Chopra S (2001) Sickle cell hepatopathy. Hepatology 33: 1021–8

    Article  PubMed  CAS  Google Scholar 

  33. Berry PA, Cross TJ, Thein SL et al. (2007) Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment. Clin Gastroenterol Hepatol 5: 1469–76

    Article  PubMed  Google Scholar 

  34. Ballas SK (2001) Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol 38: 30–6

    Article  PubMed  CAS  Google Scholar 

  35. Ahmed S, Shahid RK, Russo LA (2005) Unusual causes of abdominal pain: sickle cell anemia. Best Pract Res Clin Gastroenterol 19: 297–310

    Article  PubMed  Google Scholar 

  36. Switzer JA, Hess DC, Nichols FT, Adams RJ (2006) Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol 5: 501–12

    Article  PubMed  Google Scholar 

  37. Gavins F, Yilmaz G, Granger DN (2007) The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation 14: 667–81

    Article  PubMed  CAS  Google Scholar 

  38. Ohene-Frempong K, Weiner SJ, Sleeper LA et al. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91: 288–94

    PubMed  CAS  Google Scholar 

  39. Adams RJ, McKie VC, Carl EM et al. (1997) Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 42: 699–704

    Article  PubMed  CAS  Google Scholar 

  40. Bernaudin F, Verlhac S, Arnaud C et al. (2011) Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood 117: 1130–40

    Article  PubMed  CAS  Google Scholar 

  41. Pegelow CH, Macklin EA, Moser FG et al. (2002) Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 99: 3014–8

    Article  PubMed  CAS  Google Scholar 

  42. Vichinsky EP, Neumayr LD, Gold JI et al. (2010) Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA 303: 1823–31

    Article  PubMed  Google Scholar 

  43. DeBaun MR, Armstrong FD, McKinstry RC et al. (2012) Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 119: 4587–96

    Article  PubMed  CAS  Google Scholar 

  44. Almeida A, Roberts I (2005) Bone involvement in sickle cell disease. Br J Haematol 129: 482–90

    Article  PubMed  Google Scholar 

  45. Anyaegbu CC, Okpala IE, Aken’ova AY, Salimonu LS (1999) Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia. APMIS 107: 699–702

    Article  PubMed  CAS  Google Scholar 

  46. Halasa NB, Shankar SM, Talbot TR et al. (2007) Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 44: 1428–33

    Article  PubMed  CAS  Google Scholar 

  47. Overturf GD (2003) Prevention of invasive pneumococcal infection in sickle cell disease: on the threshold of a new era of successes? J Pediatr 143: 423–5

    Article  PubMed  Google Scholar 

  48. Lazio MP, Costello HH, Courtney DM et al. (2010) A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic. Clin J Pain 26: 199–205

    Article  PubMed  Google Scholar 

  49. Zempsky WT (2009) Treatment of sickle cell pain: fostering trust and justice. JAMA 302: 2479–80

    Article  PubMed  Google Scholar 

  50. Aisiku IP, Smith WR, McClish DK et al. (2009) Comparisons of high versus low emergency department utilizers in sickle cell disease. Ann Emerg Med 53: 587–93

    Article  PubMed  Google Scholar 

  51. Charache S, Terrin ML, Moore RD et al. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332: 1317–22

    Article  PubMed  CAS  Google Scholar 

  52. Vivien B, Adnet F, Bounes V et al. (2012) Sédation et analgésie en structure d’urgence. Ann Fr Anesth Reanim 29: 934–9

    Google Scholar 

  53. van Beers EJ, van Tuijn CF, Nieuwkerk PT et al. (2007) Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 82: 955–60

    Article  PubMed  Google Scholar 

  54. Melzer-Lange MD, Walsh-Kelly CM, Lea G et al. (2004) Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. Pediatr Emerg Care 20: 2–4

    Article  PubMed  Google Scholar 

  55. McQuay H (1999) Opioids in pain management. Lancet 353: 2229–32

    Article  PubMed  CAS  Google Scholar 

  56. Aymard G, Warot D, Demolis P et al. (2003) Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers. Pharmacol Toxicol 92: 279–86

    Article  PubMed  CAS  Google Scholar 

  57. Bartolucci P, El Murr T, Roudot-Thoraval F et al. (2009) A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults. Blood 114: 3742–7

    Article  PubMed  CAS  Google Scholar 

  58. Fartoukh M, Lefort Y, Habibi A et al. (2010) Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study. Intensive Care Med 36: 1355–62

    Article  PubMed  Google Scholar 

  59. Mantadakis E, Ewalt DH, Cavender JD et al. (2000) Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism. Blood 95: 78–82

    PubMed  CAS  Google Scholar 

  60. Roupret M, Beley S, Traxer O et al. (2005) Management of priapism in patients with sickle-cell anaemia. Prog Urol 15: 392–6; discussion 396-7

    PubMed  Google Scholar 

  61. Rogers ZR (2005) Priapism in sickle cell disease. Hematol Oncol Clin North Am 19: 917–28, viii

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Santin .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Paris

About this chapter

Cite this chapter

Santin, A., Renaud, B. (2013). Drépanocytose et complications aiguës. In: Maladies rares en médecine d’urgence. Références en médecine d’urgence. Collection de la SFMU. Springer, Paris. https://doi.org/10.1007/978-2-8178-0350-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0350-0_17

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0349-4

  • Online ISBN: 978-2-8178-0350-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics